Article
OliTag-seq enhances in cellulo detection of CRISPR-Cas9 off-targets.
Communications biology - 6 Jun 2024
Yang Zhi-Xue, Deng Dong-Hao, Gao Zhu-Ying, Zhang Zhi-Kang, Fu Ya-Wen, Wen Wei, Zhang Feng, Li Xiang, Li Hua-Yu, Zhang Jian-Ping, Zhang Xiao-Bing
Abstract excerpt
The potential for off-target mutations is a critical concern for the therapeutic application of CRISPR-Cas9 gene editing. Current detection methodologies, such as GUIDE-seq, exhibit limitations in oligonucleotide integration efficiency and sensitivity, which could hinder their utility in clinical settings. To address these issues, we introduce OliTag-seq, an in-cellulo assay specifically engineered to enhance the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
